What is Denali Therapeutics Inc. Common Stock's Market Cap?

Denali Therapeutics Inc. Common Stock's Market Cap is $3.5B, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's Enterprise Value?

Denali Therapeutics Inc. Common Stock's Enterprise Value is $2.8B, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's Price / Sales?

Denali Therapeutics Inc. Common Stock's Price / Sales is 979.3×, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's EV / Revenue?

Denali Therapeutics Inc. Common Stock's EV / Revenue is 783.7×, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's EV / EBITDA?

Denali Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's Revenue (TTM)?

Denali Therapeutics Inc. Common Stock's Revenue (TTM) is $3.6M, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's Net Income (TTM)?

Denali Therapeutics Inc. Common Stock's Net Income (TTM) is -$511.5M, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's EBITDA?

Denali Therapeutics Inc. Common Stock's EBITDA is -$530.5M, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Denali Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -3.20, based on as-reported figures from SEC (XBRL) filings.

What is Denali Therapeutics Inc. Common Stock's EBITDA Margin?

Denali Therapeutics Inc. Common Stock's EBITDA Margin is -14718.9%, based on as-reported figures from SEC (XBRL) filings.

Denali Therapeutics Inc. Common Stock (DNLI) Financial Statements

Denali Therapeutics Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG008P7F878

XNAS · usd

22.08▼ 0.20 (-0.90%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close22.28

Day's Range21.66 – 22.25

52-Week Range12.58 – 27.30

Volume1.7M

Avg Volume1.3M

Share Statistics

Shares Outstanding

Employees503

ExchangeXNAS

Listed2017-12-08

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Denali Therapeutics Inc. Common Stock (DNLI)

What is Denali Therapeutics Inc. Common Stock's Market Cap?: Denali Therapeutics Inc. Common Stock's Market Cap is $3.5B, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's Enterprise Value?: Denali Therapeutics Inc. Common Stock's Enterprise Value is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's Price / Sales?: Denali Therapeutics Inc. Common Stock's Price / Sales is 979.3×, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's EV / Revenue?: Denali Therapeutics Inc. Common Stock's EV / Revenue is 783.7×, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's EV / EBITDA?: Denali Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's Revenue (TTM)?: Denali Therapeutics Inc. Common Stock's Revenue (TTM) is $3.6M, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's Net Income (TTM)?: Denali Therapeutics Inc. Common Stock's Net Income (TTM) is -$511.5M, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's EBITDA?: Denali Therapeutics Inc. Common Stock's EBITDA is -$530.5M, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Denali Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -3.20, based on as-reported figures from SEC (XBRL) filings.
What is Denali Therapeutics Inc. Common Stock's EBITDA Margin?: Denali Therapeutics Inc. Common Stock's EBITDA Margin is -14718.9%, based on as-reported figures from SEC (XBRL) filings.